← back to search

Jenny Donovan

Bristol Regional Medical Center · GB
Area of research
Pulmonary and Respiratory Medicine · Public Health, Environmental and Occupational Health
Research interest
Research interests include Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, Ethics in Clinical Research, and Health Systems, Economic Evaluations, Quality of Life.
h-index
112
citations
52,012
works
900
NIH funding
primary concept
email

Recent publications

Long-term outcomes of cribriform-positive and cribriform-negative prostate cancer treated with radical prostatectomy in the ProtecT trial.
2026cited by 1position: contributordoi
Development and application of quality assurance methods for interventions in randomised controlled trials of surgical oncology: the ROMIO study (a comparison of minimally invasive and open oesophagectomy).
2026cited by 1position: contributordoi
Patient-reported outcome measures in prostate research: a scoping review.
2026cited by 0position: contributordoi
De-implementation of healthcare interventions post-COVID-19: evidence from the Evidence-Based Interventions (EBI) programme in England.
2026cited by 0position: contributordoi
Exploring spillover effects following surgical de-implementation: an observational evaluation of primary care, referrals, and time to surgical intervention following reductions in the use of tonsillectomy and Dupuytren's contracture.
2026cited by 0position: contributordoi
Roux-en-Y gastric bypass, adjustable gastric banding or sleeve gastrectomy for severe obesity: The By-Band-Sleeve randomised controlled trial.
2026cited by 0position: contributordoi
Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study.
2026cited by 0position: contributordoi
Changes in the Diagnosis and Treatment of Localised Prostate Cancer Following the Introduction of MRI: A Population Based Registry Study (2013-2019)
2026cited by 0position: contributordoi
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial.
2025cited by 46position: contributordoi
Active Monitoring, Surgery, and Radiotherapy for Cribriform-Positive and Cribriform-Negative Prostate Cancer
JAMA Oncology 2025cited by 12position: middledoi
Roux-en-Y gastric bypass, adjustable gastric banding, or sleeve gastrectomy for severe obesity (By-Band-Sleeve): a multicentre, open label, three-group, randomised controlled trial.
2025cited by 7position: contributordoi
Active Monitoring, Surgery, and Radiotherapy for Cribriform-Positive and Cribriform-Negative Prostate Cancer: A Secondary Analysis of the PROTECT Randomized Clinical Trial.
2025cited by 5position: contributordoi
Lessons from using the Normalisation Process Theory to understand adherence to guidance on MgSO<sub>4</sub> in preterm labour.
2025cited by 1position: contributordoi
Relevance and flexibility are key: exploring healthcare managers' views and experiences of a de-adoption programme in the English National Health Service.
2025cited by 1position: contributordoi
Delivering a national de-adoption programme: a documentary analysis of local commissioning policy compliance with England's Evidence-based Interventions programme (EBI).
2025cited by 0position: contributordoi
Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality
JAMA 2024cited by 90position: middledoi
Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial.
2024cited by 68position: contributordoi
Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis
EBioMedicine 2024cited by 44position: middledoi
Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis
eBioMedicine 2024cited by 41position: contributordoi
Medical management and surgery versus medical management alone for symptomatic cerebral cavernous malformation (CARE): a feasibility study and randomised, open, pragmatic, pilot phase trial.
2024cited by 16position: contributordoi
Laparoscopic or open abdominal surgery with thoracotomy for patients with oesophageal cancer: ROMIO randomized clinical trial.
2024cited by 15position: contributordoi
Quality improvement interventions to increase the uptake of magnesium sulphate in preterm deliveries for the prevention of cerebral palsy (PReCePT study): a cluster randomised controlled trial.
2024cited by 7position: contributordoi
Preparing for responsive management versus preparing for renal dialysis in multimorbid older people with advanced chronic kidney disease (Prepare for Kidney Care): Study protocol for a randomised controlled trial.
2024cited by 4position: contributordoi
Reply to Bernardo Rocco and Maria Chiara Sighinolfi's Letter to the Editor re: Freddie C. Hamdy, Jenny L. Donovan, J. Athene Lane, et al. Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med 2023;388:1547-58.
2024cited by 3position: contributordoi
Addressing barriers and identifying facilitators to support informed consent and recruitment in the Cavernous malformations A Randomised Effectiveness (CARE) pilot phase trial: insights from the integrated QuinteT recruitment intervention (QRI).
2024cited by 3position: contributordoi
From a genomic risk model to clinical trial implementation in a learning health system: the ProGRESS Study
medRxiv 2024cited by 3position: middledoi
The role of healthcare professionals' communication in trial participation decisions: a qualitative investigation of recruitment consultations and patient interviews across three RCTs.
2024cited by 2position: contributordoi
Reply to Greg Shaw, John D. Kelly, and Monique J. Roobol's Letter to the Editor re: Freddie C. Hamdy, Jenny L. Donovan, J. Athene Lane, et al. Fifteen-Year Outcomes After Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med 2023;388:1547-58.
2024cited by 1position: contributordoi
Screening and active surveillance in prostate cancer: the dilemma continues.
2024cited by 0position: contributordoi
Re: Freddie C. Hamdy, Jenny L. Donovan, J. Athene Lane, et al. Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med 2023; 388:1547-58.
2024cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Freddie C. Hamdy · Oxford BioMedica (United Kingdom)33 papers (2012–2025)Richard M. Martin · Ursuline College29 papers (2019–2024)Chris Metcalfe · At Bristol28 papers (2013–2026)Jane M Blazeby · University Hospitals Bristol NHS Foundation Trust24 papers (2019–2026)J Athene Lane · Royal North Shore Hospital23 papers (2019–2026) · 16 papers (2021–2026)David E. Neal · University of Oxford15 papers (2012–2025)Daisy Elliott · University Hospitals Bristol NHS Foundation Trust14 papers (2017–2024)T. J. Peters · Colorado State University Pueblo13 papers (2019–2024)Jyotsna Batra · Addenbrooke's Hospital13 papers (2019–2024)Natalie Blencowe · Leeds Teaching Hospitals NHS Trust12 papers (2019–2026)James W.F. Catto · University of Sheffield11 papers (2019–2023)Johanna Schleutker · Praxis für Humangenetik Tübingen9 papers (2019–2023)Zsofia Kote-Jarai · Icahn School of Medicine at Mount Sinai9 papers (2019–2024)Chris Rogers · University of Wolverhampton9 papers (2019–2026) · 8 papers (2023–2023)Ana Vega · Victorian Comprehensive Cancer Centre8 papers (2019–2023)Stella Koutros · Onco-Urologie Prédictive7 papers (2019–2020)Kerry Avery · Medical Research Council7 papers (2019–2023)Frank Claessens · Lund University7 papers (2019–2023)